Navigation Links
CVBT Interim Board of Directors Remains In Place
Date:6/20/2013

LAS VEGAS, June 21, 2013 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (CVBT) announced today that the Delaware Court of Chancery ruled that Mickael A. Flaa, Grant Gordon, Calvin A. Wallen III, Jon Ross, and Robert Schleizer will remain in place as the CVBT Board of Directors pending resolution of the lawsuit filed on June 9, 2013, by Mickael A. Flaa in that Court.  The Delaware lawsuit seeks, among other things, to confirm the validity of the action by written consent of stockholders on June 7, 2013, to remove Daniel C. Montano, John (Jack) Jacobs, Ernest C. Montano, Viktoriya T. Montano, Ernest Montano III, and Joong Ki Baik as directors of CVBT.  Pending resolution of the Delaware lawsuit, or further order of the Delaware Court of Chancery, the power of CVBT's interim Board of Directors to take certain [extraordinary] actions on behalf of CVBT will be limited by a status quo order, which has not yet been entered.

About CardioVascular BioTherapeutics
CVBT is a biopharmaceutical company developing drug candidates with FGF-1 as its active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to tissue or organs. The company is the sponsor of a Phase II trial to treat severe coronary heart disease (CVBT-141H), and has received FDA authorization for a Phase I trial to treat peripheral arterial disease (CVBT-141C). A Late-Stage trial to treat chronic diabetic foot ulcers (CVBT-141B) is planned pending FDA approval.

Forward
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013
2. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
3. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
4. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
5. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
7. OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
8. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
9. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Golden Meditech Announces 2012 / 2013 Interim Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Advanced Wound Dressings - SA Analysis ... have steadily replaced traditional bandages and gauze materials ... indications, such as trauma wounds, burns, and chronic ... protection become increasingly critical in wound healing, advanced ... This report focuses on nine market categories ...
(Date:9/2/2015)... , Sept. 2, 2015 Advanced Wound ... Summary Advanced dressings have steadily replaced traditional ... a variety of wound indications, such as trauma ... infection control, and physical protection become increasingly critical ... role in standard therapy. This report focuses ...
(Date:9/2/2015)... , Sept. 2, 2015 ... diversifies revenue base with highly profitable specialty products ... , Near-term growth potential with 11 product applications ... Paragraph IV certifications  , Provides medium and ... in development, including eight controlled substances , ...
Breaking Medicine Technology:Advanced Wound Dressings - SA Analysis and Market Forecasts 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6
... Inc. (Nasdaq: CRDC ) today announced that it ... December 31, 2011, on Monday, February 6, 2012, after the ... 4:30 p.m. Eastern Time to discuss the financial results and ... Conference Call Details To access the ...
... 2012  The IP & Science business of Thomson ... Applied Economic Research (IPEA). This partnership provides IPEA,s ... Regulation and Infrastructure (DISET) branch with access to ... generic pharmaceutical intelligence and tools for sourcing global ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities 2
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an ... Google Play , and Amazon and will be released on DVD early ... Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, lead from ...
(Date:9/3/2015)... ... 2015 , ... At Renew Man™, we have seen an increasing number of ... where the primary care physician dictates and the patient obeys. Instead, our clients are ... health issues and empowered to choose their own treatment options. , Recognizing that many ...
(Date:9/3/2015)... , ... September 03, 2015 , ... James Earl Jones ... workplace wellness. In this episode, James Earl Jones will introduce a segment that discusses ... unhealthy workplace and how workplace wellness can be fostered in any working environment. , ...
(Date:9/3/2015)... ... September 03, 2015 , ... Fashion designer Kim (29 years old, ... most recent episode of the hit ABC series “Extreme Weight Loss” Season 5 ... her industry. She provided herself with the motivation to transform when she designed a ...
(Date:9/2/2015)... ... September 03, 2015 , ... Sara ... Bloomberg School of Public Health and an internationally recognized scholar on obesity prevention ... 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of Garrison Forest School, ...
Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... international team of scientists led by researchers at the University ... pluripotent stem cells (iPSCs) derived from patients with amyotrophic lateral ... levels of a specific protein may play a central role ... The work, published in the June 2011 online issue ...
... By Alan Mozes HealthDay Reporter , TUESDAY, June ... research suggests that repeated bouts of unemployment don,t affect everyone ... people who are consistently successful in finding new work after ... so-called "serial joblessness" than are those who lose a job ...
... strong evidence indicates that policies beyond the health sector ... U.S. government should adopt a structured approach to considering ... says a new report by the Institute of Medicine. ... and revise public health laws so that they adequately ...
... Reporter , MONDAY, June 20 (HealthDay News) -- Evaluating ... lower blood pressure requires multiple readings, new research suggests. ... condition known as "white coat" hypertension, so readings should ... study,s lead author, Dr. Benjamin Powers, assistant professor of ...
... laid, their natural resistance to pathogens begins to wear down, ... rearm those defenses. Kevin Keener, an associate professor of ... is designed to inhibit the growth of bacteria such as ... an egg with carbon dioxide and alter pH levels, which ...
... cancer who don,t live near a major academic medical center ... The University of Alabama at Birmingham Comprehensive Cancer Center ... bring leading-edge care to these communities, giving patients an opportunity ... access to leading cancer research. The UAB ...
Cached Medicine News:Health News:Stem cell model offers clues to cause of inherited ALS 2Health News:Unemployment May Hit Some Harder Than Others 2Health News:Unemployment May Hit Some Harder Than Others 3Health News:Unemployment May Hit Some Harder Than Others 4Health News:Government should consider public health implications of all major legislation 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 3Health News:Cooling system may build eggs' natural defenses against salmonella 2Health News:UAB Comprehensive Cancer Center launches Cancer Care Network 2
... is an economically priced 4-channel data ... research use in the fields of ... biology, zoology, biochemistry and biomedical engineering. ... signal conditioners and transducers. Two Pod ...
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
Tumbling E/20' distance chart 22-1/2" X 11" 20/200 to 20/10....
... charts contain 5 pages of various contrast levels ... size is 9.5M. Contrast levels are 25%, 10%, ... be used at several different distances. These two ... offers a different set of symbols to ...
Medicine Products: